logo

For the Inventor, By the Inventor

Okayama, Japan

Momotaro-Gene Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 30.0



Forward Citations = 23

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Hiromi Kumon (10 out of 15 patents)

silverMedal Masami Watanabe (7 out of 8 patents)

bronzeMedal Yasutomo Nasu (4 out of 7 patents)

4.  Masakiyo Sakaguchi (3 out of 9 patents)

5.  Yuji Kashiwakura (3 out of 3 patents)

6.  Junichiro Futami (2 out of 7 patents)

7.  Nam-Ho Huh (2 out of 5 patents)

8.  Chae Ok Yun (1 out of 19 patents)

9.  Richard Lowenthal (1 out of 8 patents)

10.  Rie Kinoshita (1 out of 2 patents)

11.  Hideo Ueki (1 out of 1 patent)

12.  Yasuyuki Fujii (1 out of 1 patent)

13.  Kazuhiko Ochiai (1 out of 1 patent)

14.  Namho Huh (1 out of 1 patent)

15.  Kensuke Kawasaki (1 out of 1 patent)


10 patents:

1. 11951182 - Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor (2024-04-09),
2. 11484592 - Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor (2022-11-01),
3. 10782296 - Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibody (2020-09-22),
4. 10071126 - Conditionally replicating adenovirus to express REIC gene (2018-09-11),
5. 9644013 - Partial region polypeptide of REIC/Dkk-3 protein (2017-05-09),
6. 9493776 - System for increasing gene expression and vector comprising the system (2016-11-15),
7. 9222107 - REIC-expressing adenovirus vector (2015-12-29),
8. 8946173 - Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer (2015-02-03),
9. 8658612 - Therapeutic agent for malignant mesothelioma and immunostimulant (2014-02-25),
10. 8614093 - Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity (2013-12-24),
Company Overview
Momotaro-Gene Inc. is a biotechnology company based in Okayama, Japan, specializing in the development of innovative gene therapies and regenerative medicine solutions. The organization focuses on harnessing advanced genetic engineering techniques to address various health challenges, aiming to improve patient outcomes through targeted treatments. With a commitment to research and development, Momotaro-Gene is positioned at the forefront of biomedicine, contributing to the evolving landscape of therapeutic options in the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#17 in Okayama

#4,406 in Japan

#56,119 in the World

Okayama, JP
Okayama, Japan

Momotaro-Gene Inc.

Forward Citations = 23

16 inventors:

goldMedal Hiromi Kumon (10 out of 15 patents)

silverMedal Masami Watanabe (7 out of 8 patents)

bronzeMedal Yasutomo Nasu (4 out of 7 patents)

4.  Masakiyo Sakaguchi (3 out of 9 patents)

5.  Yuji Kashiwakura (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Momotaro-Gene Inc.. Retrieved from https://idiyas.com/company/momotaro-gene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…